Medical device maker Medtronic has started testing on a new pelvic stent for those men who have not been help by Viagra, Cialis, and Levitra. Researchers will begin with 50 patients at 10 different medical centers across the U.S.
There are approximately 25 million men with erectile dysfunction (ED) who do not respond to the drug treatments and a new Medtronic study could show some hope for those patients. The 50-patient study was launched last week and results are expected by 2011. Participants in the research must have had suboptimal responses to the drug treatments for ED. The research will assess the safety and improved erectile function of pelvic artery stenting.
The stent system is based on technology created in Santa Rosa which involves small tubes generally used to prop open clogged arteries â€” in the pelvic arteries of 50 patients who suffer from ED linked to coronary heart disease.
The lead researcher of the study. Dr. Jason Rogers, Director, Interventional Cardiology at UC Davis Medical Centre, Sacramento says there is a well-established link between erectile dysfunction and coronary artery disease. Supported by this data, the research will investigate stent use in pelvic arteries for determining whether a new treatment approach may provide and enable better response to drug therapies. Study results are expected in 2011.